Chad Alford, MD
Interventional Cardiology · Mobile, ALNPI 1114905429
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Abbott at 46.5% of the total. Reporting peaked in 2023 at $154 and has fallen 50.5% since, to $76 in 2025. That places this record below the midpoint for interventional cardiology clinicians in AL, where the typical reported total is $6,630.
Across 11 payments — averaging $36.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$187
- Boehringer Ingelheim$59
- Inari Medical, Inc.$59
- Stryker$33
- Hologic Sales And Service, LLC$25
- Amgen$21
- plus $18 from 1 others
Across 12 payments — averaging $38,395 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$448K
- Merck$12K
- Janssen Research & Development, LLC$15
What the payments were for
- Food & beverage$404100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 3 | $187 |
| Boehringer Ingelheim | 2 | $59 |
| Inari Medical, Inc. | 2 | $59 |
| Stryker | 1 | $33 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Amgen | 1 | $21 |
| GSK | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$129
How this compares
$404 in reported general payments places this provider in the 0th percentile of 109 interventional cardiology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 457 | $441,646 |
| XareltoRivaroxaban | 111 | $112,677 |
| Repatha SureclickEvolocumab | 23 | $31,447 |
| EntrestoSacubitril/Valsartan | 15 | $21,832 |
| MultaqDronedarone Hcl | 21 | $15,527 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 201 | $9,890 |
| Metoprolol Succinate | 563 | $8,712 |
| BrilintaTicagrelor | 12 | $7,593 |
| Atorvastatin Calcium | 490 | $6,840 |
| VascepaIcosapent Ethyl | 18 | $5,379 |
| Potassium Chloride | 198 | $4,893 |
| Amlodipine Besylate | 613 | $4,024 |
| Rosuvastatin Calcium | 237 | $3,804 |
| Ranolazine ErRanolazine | 45 | $3,749 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 12 | $3,684 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Mobile
- John GallaMobile$82K
- Ahmed SubahiMobile$37K
- Mir HashimiMobile$24K
- Mohammed ElzeneiniMobile$23K
- Benjamin CitrinMobile$11K
- James GladdenMobile$9K
- Stanley ThorntonMobile$7K
- Michael MonsonMobile$7K
- Kevin DeandradeMobile$7K
- Gary RoubinBirmingham$157K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.